At the beginning of the third week of the month, Wall Street recorded a session with positive bias , away from the tensions of the weekend between the United States and Russia on the attack on Syria and focusing attention on the second day of corporate results. Thus, the Dow Jones industrial average advanced 0.87 percent to 24 thousand 573.04 points, the S & P 500 rose 0.88 percent to 2 thousand 679.53 units, its highest level in almost a month, and the Nasdaq technology appreciated 0.70 percent to 7 thousand 156.29 points, relying on the profits of titles of companies in the health sector and technology. In economic data, retail sales in March rose 0.6 percent and in its annual comparison, rose 4.5 percent, breaking a three-month rolling streak as a result of an increase in car sales, as well as related ones. with health and personal care that could signal a boost in economic growth corresponding to the first quarter. In the energy sector, samples of the oil mix fell more than one percent on both sides of the Atlantic, after registering its highest weekly percentage increase since the end of July last year. Brent in London closed at 71.42 dollars per barrel a drop of 1.06 percent and the WTI at 66.22 dollars per barrel, down 1.74 percent. In information from the Fed, a senior White House official announced that President Donald Trump will appoint economist Richard Clarida, strategic adviser to the PIMCO investment fund, as vice president of the Federal Reserve. If confirmed this move to the number two in importance of the agency, it would be becoming official to replace Stranley Fischer, who resigned as vice president last October. Clarida “is just what Jay needs,” said Timothy Adams, president of the Institute of International Finance in an interview with Bloomberg. In the stock market, some of the broadcasters that presented the main rises were United Health, with an advance of 2.61 percent awaiting its earnings report tomorrow, followed by Merck, Verizon and Microsoft. The Merck pharmaceutical titles were driven by lung cancer research and results, once again beating their eternal competitors Bristol Myers and Nektar. In this respect, the Bristol Myers and Nektar titles led the day’s falls with a decline of 7.79 percent and 7.25 percent, followed by National Oilwell and Foot locker. During the day, reports from Bank of America and Netflix stood out. In Mexico, the Index of Prices and Quotes recorded a healthy profit taking and fell 0.68 percent to conclude the day in 48 thousand 434.39 units, in the absence of local economic data but good prospects and optimism among investors from a favorable perspective on NAFTA. In the stock market, the titles that led the main increases were Grupo Aeroportuario del Centro Norte, which achieved an advance of 1.93 percent, followed by Alpek, Volaris and Grupo Televisa. On the contrary, the stations that fell were Nemak, with a fall of 4.45 percent, followed by Industrias Peñoles, Grupo México and Cemex. Tomorrow, Banco de México will announce the status of international reserves.